Riskpilot← Back to searchSign inGet full accessCorpus Effectum AB
ABActiveOrg 5592539752Toredalsvägen 26Beauty care and other beauty treatment activities · NACE 9622Est. 20201 employees
Revenue 2024
SEK 1,1M
+43% vs 2023
EBITDA margin
12.6%
+1249% vs 2023
Equity ratio
70.3%
Financial strength
Net profit 2024
SEK 125K
+1105% vs 2023
| Revenue | SEK 1,1M | +43% |
| EBITDA | SEK 137K | +1249% |
| Net profit | SEK 125K | +1105% |
| Total assets | SEK 355K | +66% |
| Equity | SEK 249K | +101% |
| Employees | 1 | — |
Legal name
Corpus Effectum AB
Org number
5592539752
Legal form
Aktiebolag
NACE code
9622 · Beauty care and other beauty treatment activities
Founded
28 april 2020
Share capital
SEK 25 000
Employees
1 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas var för sig av ledamöterna
Company purpose
Konsultverksamhet avseende företagsorg. Friskvård, kroppsbehandlingar och medicinsk fotvård. Inredning, växter. Kursverksamhet. Webbförsäljning av kropps- och fotvårds- produkter.
Address
Toredalsvägen 26
Email
m.hedfors@corpuseffectum.se
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 2 | 234 | 566 | 765 | 1 094 |
| Staff expenses | — | — | −220 | −532 | −667 |
| EBITDA | −126 | 72 | −37 | 10 | 137 |
| Depreciation & amort. | −0 | −0 | — | — | — |
| EBIT | −126 | 72 | −37 | 10 | 137 |
| Net financials | — | — | 0 | 0 | 0 |
| Profit before tax | −126 | 72 | −37 | 10 | 138 |
| Tax | −0 | −0 | — | — | −13 |
| Net profit | −126 | 72 | −37 | 10 | 125 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 73 | 149 | 147 | 213 | 355 |
| Equity | 29 | 101 | 64 | 124 | 249 |
| Long-term debt | 0 | 0 | — | — | — |
| Short-term debt | 44 | 47 | 83 | 89 | 105 |
| Total debt | 44 | 47 | 83 | 89 | 105 |
EBITDA margin
12.6%
This company
15.8%
Market median
-20% vs market
20202024
Equity ratio
70.3%
This company
38.2%
Market median
+84% vs market
20202024
Return on equity
50.1%
This company
18.4%
Market median
+172% vs market
20202024
Net profit margin
11.4%
This company
8.1%
Market median
+41% vs market
20202024
Asset turnover
3.08×
This company
1.12×
Market median
+175% vs market
20202024
Debt / equity
0.42×
This company
0.62×
Market median
+32% vs market
20202024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-04-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
ME Chief Executive Officer | Chief Executive Officer | 2021 |
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Chairman | 2025 | |
| Deputy Board Member | 2021 | |
| Former (1) | ||
| Deputy Board Member | 2021 – 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Corpus Effectum AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Marie Elisabet Hedfors | Chief Executive Officer | 0 companies |
| Magnus Andreas Hedfors | Deputy Board Member | 0 companies |
| Magnus Olov Hedfors | Chairman | 0 companies |
| Hans Daniel Hedfors | Deputy Board Member | 0 companies |